ES2368089T3 - Derivados de 4-(3-benzoilaminofenil)-6,7-dimetoxi-2-metilaminoquinazolina. - Google Patents

Derivados de 4-(3-benzoilaminofenil)-6,7-dimetoxi-2-metilaminoquinazolina. Download PDF

Info

Publication number
ES2368089T3
ES2368089T3 ES07714569T ES07714569T ES2368089T3 ES 2368089 T3 ES2368089 T3 ES 2368089T3 ES 07714569 T ES07714569 T ES 07714569T ES 07714569 T ES07714569 T ES 07714569T ES 2368089 T3 ES2368089 T3 ES 2368089T3
Authority
ES
Spain
Prior art keywords
compound
salt
hydrate
dimethoxy
methylaminoquinazolin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
ES07714569T
Other languages
English (en)
Spanish (es)
Inventor
Kazuki Miyazaki
Kazutomi Kusano
Yasutaka Takase
Osamu Asano
Manabu Shirato
Hisashi Wakita
Naoto Ishii
Takao Saeki
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Eisai R&D Management Co Ltd
Original Assignee
Eisai R&D Management Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Eisai R&D Management Co Ltd filed Critical Eisai R&D Management Co Ltd
Application granted granted Critical
Publication of ES2368089T3 publication Critical patent/ES2368089T3/es
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/70—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings condensed with carbocyclic rings or ring systems
    • C07D239/72—Quinazolines; Hydrogenated quinazolines
    • C07D239/78—Quinazolines; Hydrogenated quinazolines with hetero atoms directly attached in position 2
    • C07D239/84—Nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
ES07714569T 2006-02-21 2007-02-20 Derivados de 4-(3-benzoilaminofenil)-6,7-dimetoxi-2-metilaminoquinazolina. Active ES2368089T3 (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2006043273 2006-02-21
JP2006043273 2006-02-21

Publications (1)

Publication Number Publication Date
ES2368089T3 true ES2368089T3 (es) 2011-11-14

Family

ID=42137992

Family Applications (1)

Application Number Title Priority Date Filing Date
ES07714569T Active ES2368089T3 (es) 2006-02-21 2007-02-20 Derivados de 4-(3-benzoilaminofenil)-6,7-dimetoxi-2-metilaminoquinazolina.

Country Status (18)

Country Link
JP (1) JP4778550B2 (el)
KR (1) KR101278852B1 (el)
AT (1) ATE517875T1 (el)
BR (1) BRPI0708098B8 (el)
CY (1) CY1112554T1 (el)
DK (1) DK1992622T3 (el)
ES (1) ES2368089T3 (el)
HK (1) HK1122025A1 (el)
HR (1) HRP20110604T1 (el)
IL (1) IL193322A (el)
JO (1) JO2726B1 (el)
MY (1) MY146275A (el)
NZ (1) NZ569936A (el)
PT (1) PT1992622E (el)
RS (1) RS51969B (el)
RU (1) RU2431632C2 (el)
SI (1) SI1992622T1 (el)
TW (1) TWI404709B (el)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2008099887A1 (ja) 2007-02-16 2008-08-21 Eisai R & D Management Co., Ltd. メチル ｎ－［３－（６，７－ジメトキシ－２－メチルアミノキナゾリン－４－イル）フェニル］テレフタラミックアシッドの結晶、非晶質体または塩
EP2189450B1 (en) 2007-08-17 2011-12-21 Eisai R&D Management Co., Ltd. Method for producing quinazoline derivative
JP5060561B2 (ja) 2007-08-17 2012-10-31 エーザイ・アール・アンド・ディー・マネジメント株式会社 新規外用剤

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AR015966A1 (es) * 1997-10-17 2001-05-30 Smithkline Beecham Corp Uso de un compuesto inhibidor de pde4 para la preparacion de un medicamento util para el tratamiento de prurito
JPH11209350A (ja) 1998-01-26 1999-08-03 Eisai Co Ltd 含窒素複素環誘導体およびその医薬

Also Published As

Publication number Publication date
RU2431632C2 (ru) 2011-10-20
RS51969B (en) 2012-02-29
PT1992622E (pt) 2011-09-19
HK1122025A1 (el) 2009-05-08
TW200812980A (en) 2008-03-16
SI1992622T1 (sl) 2011-11-30
KR20080094811A (ko) 2008-10-24
CY1112554T1 (el) 2016-02-10
TWI404709B (zh) 2013-08-11
DK1992622T3 (da) 2011-09-05
MY146275A (en) 2012-07-31
IL193322A (en) 2014-04-30
BRPI0708098B8 (pt) 2021-05-25
JO2726B1 (en) 2013-09-15
KR101278852B1 (ko) 2013-07-01
JP4778550B2 (ja) 2011-09-21
BRPI0708098B1 (pt) 2019-08-06
HRP20110604T1 (hr) 2011-09-30
ATE517875T1 (de) 2011-08-15
NZ569936A (en) 2010-07-30
IL193322A0 (en) 2009-05-04
BRPI0708098A2 (pt) 2011-05-17
RU2008137654A (ru) 2010-03-27
JPWO2007097317A1 (ja) 2009-07-16

Similar Documents

Publication Publication Date Title
US11485726B2 (en) Compound for inhibiting and degrading tyrosine protein kinase ALK
JP5596139B2 (ja) 二置換フタラジンヘッジホッグ経路アンタゴニスト
JP4405602B2 (ja) ヒストン脱アセチル化酵素阻害剤
ES2528796T3 (es) Benzo[c]fenantridinas pseudobásicas con eficacia, estabilidad y seguridad mejoradas
WO2021190467A1 (zh) 含螺环的喹唑啉化合物
AU2009241561B2 (en) Disubstituted phthalazine hedgehog pathway antagonists
WO2021027911A1 (zh) 新型螺环类K-Ras G12C抑制剂
EP1992622B1 (en) 4-(3-benzoylaminophenyl)-6,7-dimethoxy-2- methylaminoquinazoline derivative
CN112300153B (zh) 一种杂环化合物、药物组合物和用途
JPWO2009025239A1 (ja) 新規外用剤
US9981946B2 (en) Pyridine-substituted 2-aminopyridine protein kinase inhibitors
AU2008215411B2 (en) Crystal, amorphous form and salt of methyl N-[3-(6,7-dimethoxy- 2-methylaminoquinazolin-4-yl)phenyl]terephthalamic acid
TW200410695A (en) Quinazolinone derivatives useful as anti-hyperalgesic agents
ES2958528T3 (es) Macrociclos sustituidos útiles como inhibidores de quinasas
JP5404607B2 (ja) 抗ｒｎａウイルス作用を有するアニリン誘導体
ES2368089T3 (es) Derivados de 4-(3-benzoilaminofenil)-6,7-dimetoxi-2-metilaminoquinazolina.
CN116375704A (zh) Krasg12c突变蛋白异喹啉酮类抑制剂的制备及其应用
WO2023168740A1 (zh) 喹啉类化合物的新用途
WO2023206655A1 (zh) 一种PI3Kδ抑制剂及其用途
An et al. Inhibition of TGF-β1/Smad3 signaling by compound 5aa: A potential treatment for idiopathic pulmonary fibrosis
JP5102230B2 (ja) メチルｎ−［３−（６，７−ジメトキシ−２−メチルアミノキナゾリン−４−イル）フェニル］テレフタラミックアシッドの結晶、非晶質体または塩
KR20090118025A (ko) 메틸 ｎ-[3-(6,7-디메톡시-2-메틸아미노퀴나졸린-4-일)페닐]테레프탈람산의 결정, 비정질체 또는 염